First Age- and Gender-Matched Case-Control Study in Australia Examining the Possible Association between Toxoplasma gondii Infection and Type 2 Diabetes Mellitus: The Busselton Health Study.

Aus Molan,Manshu Song,Xiaoni Meng,Kazunori Nosaka,Wei Wang,Michael Hunter,Jinxia Zhang

doi:10.1155/2020/3142918

Abstract

An emerging field of research is starting to examine the association of infectious pathogens with type 2 diabetes mellitus (T2DM). An understudied parasite of interest is Toxoplasma gondii. Globally, very few studies have been conducted to investigate this association. Additionally, very little data exists on the prevalence of T. gondii in the general Australian population. Our group sought to determine the prevalence, association, and risk factors between T. gondii infection and T2DM from a representative Australian human population. Through a cross-sectional, age- and gender-matched case-control study, 150 subjects with T2DM together with 150 control subjects from the Busselton Health Study cohort were investigated. Sera samples were tested for the presence of anti-T. gondii IgG and IgM antibodies using enzyme-linked immunosorbent assays. Survey-derived data were also analyzed to evaluate associated risk factors. The IgG seroprevalence was found to be 62% and 66% for the T2DM and control groups, respectively (OR : 0.84; p = 0.471). IgM antibodies were detected in 5% of the T2DM patients and in 10% of the controls (OR = 0.51; p = 0.135). There were no significant differences between male and female IgG seroprevalence rates for both groups (OR : 0.88, 0.80; p = 0.723). The IgG seropositivity rate increased significantly in T2DM patients aged 45-84 years in comparison to those aged 18-44 years (p < 0.05), but this was not observed in the control subjects. No risk factors were associated with T. gondii seropositivity in both groups. The first Australian study of its kind found T. gondii infection in Western Australia to be highly prevalent. The results also showed that there is no serological evidence of an association between T. gondii infection and T2DM in the studied subjects. Australian health authorities should focus on raising awareness of toxoplasma infection and target T. gondii transmission control. Further studies are needed to clarify the role of T. gondii in T2DM.

Highlights

Diabetes in Australia has reached an epidemic level with an estimated 6% (1.2 million) of the adult population aged 18 years and over living with the condition [1, 2]
Our investigation showed that 62.0% of the subjects with type 2 diabetes mellitus (T2DM) and 66.0% of the healthy control subjects were seropositive for anti-T. gondii IgG antibodies with no significant difference observed between the two groups (p = 0:84)
We conclude that T. gondii infection in Western Australia is highly prevalent

Summary

Introduction

Diabetes in Australia has reached an epidemic level with an estimated 6% (1.2 million) of the adult population aged 18 years and over living with the condition [1, 2]. In 2016, 1.6 million deaths were caused by diabetes worldwide [5] This is mainly due to the increase in the Journal of Parasitology Research numbers of people with T2DM as a result of the increase in life expectancy, genetic predisposition, physical inactivity, dietary changes, the obesity epidemic, and the decreased mortality rates in diabetic individuals [1]. There may be additional unidentified novel risk factors, such as subclinical inflammation caused by infectious agents, that contribute to this rising prevalence of T2DM [6] In this regard, an emerging field of research is beginning to investigate the potential of infectious and environmental pathogens to cause low-grade inflammation that may facilitate the risk and development of various metabolic conditions, including diabetes and obesity

Objectives

Methods

Results

Discussion

Conclusion